Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 4/20 | 0.57 |
| ▸ | PAM | P19021 | 1/20 | 0.54 |
| ▸ | CPA1 | P15085 | 2/20 | 0.51 |
| ▸ | CPB1 | P15086 | 1/20 | 0.51 |
| ▸ | CPA3 | P15088 | 1/20 | 0.51 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14392787 | 1.00 | CTRB1 (0.57) | CTRB1PAMCPA1CPB1CPA3 | |
| SCHEMBL27781785 | 1.00 | CTRB1 (0.57) | CTRB1PAMCPA1CPB1CPA3 | |
| SCHEMBL13296480 | 0.87 | CTRB1 (0.54) | CTRB1PAMLMNA | |
| SCHEMBL14611003 | 0.85 | CTRB1 (0.53) | CTRB1PAMLMNA | |
| SCHEMBL14392786 | 0.85 | CTRB1 (0.53) | CTRB1PAMLMNA | |
| SCHEMBL6529461 | 0.84 | MAPK1 (0.69) | CTRB1PAMMMELMNA | |
| SCHEMBL27904479 | 0.84 | HPGD (0.58) | CTRB1PAMLMNA | |
| SCHEMBL6319150 | 0.84 | MAPK1 (0.69) | CTRB1PAMMMELMNA | |
| SCHEMBL17305286 | 0.84 | HPGD (0.58) | CTRB1PAMLMNA | |
| SCHEMBL2089507 | 0.84 | MAPK1 (0.69) | CTRB1PAMMMELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858348-B2 | N-acetyl-(R,S)-beta-amino acid acylase gene | AJINOMOTO CO., INC. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | AJINOMOTO CO., INC. (JP) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241895-A1 | N-Acetyl-(R,S)-beta-Amino Acid Acylase Gene | ACSL4, FASN, BLVRB | CTRB1 4283/4885PAM 3809/4885CPA1 2925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.